首页> 美国卫生研究院文献>Preventive Nutrition and Food Science >Rumex crispus and Cordyceps militaris Mixture Ameliorates Production of Pro-Inflammatory Cytokines Induced by Lipopolysaccharide in C57BL/6 Mice Splenocytes
【2h】

Rumex crispus and Cordyceps militaris Mixture Ameliorates Production of Pro-Inflammatory Cytokines Induced by Lipopolysaccharide in C57BL/6 Mice Splenocytes

机译:Rumex crispus和Cord虫草混合物可改善脂多糖诱导的C57BL / 6小鼠脾细胞促炎性细胞因子的产生。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Rumex crispus (Rc) and Cordyceps militaris (Cm) mixture (Rc-Cm; AST2017-01) ameliorated production of proinflammatory cytokines, inflammation-related genes, and nitric oxide (NO) induced by lipopolysaccharide (LPS) in mouse splenocytes. Rc-Cm (6:4) and Taemyeongcheong (commercial healthy drink containing Rc-Cm) were co-administered along with LPS. Rc-Cm inhibited production of tumor necrosis factor α, interferon γ, interleukin (IL)-1β, and IL-6 in LPS-induced splenocytes. However, levels of inflammatory cytokines were elevated in the absence of LPS treatment. Rc-Cm significantly suppressed mRNA expression of IL-1β, IL-6, and the inflammation-related genes inducible NO synthase (iNOS) and cyclooxygenase 2 (COX-2), as well as NO production upon LPS co-treatment. Whereas Rc-Cm increased mRNA expression of IL-1β, and IL-6, but did not up-regulate expression of iNOS and COX-2, or increase NO production without LPS co-treatment. Therefore, treatment of Rc-Cm to LPS-induced splenocytes ameliorated induction of pro-inflammatory cytokines, inflammation-related genes, and NO production. In the absence of LPS, Rc-Cm treatment up-regulated pro-inflammatory cytokines but did not alter expression of the inflammation-related genes iNOS and COX-2 or NO production. These results indicate that the natural phytochemicals chrysophanol and cordycepin in Rc-Cm promote anti-inflammatory activities and immune cell responses.
机译:Rumex crispus(Rc)和mil虫草(Cm)混合物(Rc-Cm; AST2017-01)改善了小鼠脾细胞中脂多糖(LPS)诱导的促炎细胞因子,炎症相关基因和一氧化氮(NO)的产生。 Rc-Cm(6:4)和Taemyeongcheong(含Rc-Cm的商业健康饮料)与LPS并用。 Rc-Cm抑制LPS诱导的脾细胞中肿瘤坏死因子α,干扰素γ,白介素(IL)-1β和IL-6的产生。但是,在没有LPS治疗的情况下,炎性细胞因子水平升高。 Rc-Cm显着抑制IL-1β,IL-6和炎症相关基因可诱导的NO合酶(iNOS)和环氧合酶2(COX-2)的mRNA表达,以及LPS共同处理时NO的产生。而Rc-Cm增加IL-1β和IL-6的mRNA表达,但不上调iNOS和COX-2的表达,或在不进行LPS共同处理的情况下不增加NO的产生。因此,对LPS诱导的脾细胞进行Rc-Cm处理可改善促炎细胞因子,炎症相关基因和NO产生的诱导。在没有LPS的情况下,Rc-Cm处理可上调促炎细胞因子,但不会改变炎症相关基因iNOS和COX-2或NO产生的表达。这些结果表明,Rc-Cm中的天然植物化学物质香豆酚和虫草素可促进抗炎活性和免疫细胞反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号